Medicare Enrolled

Dr. Aziz Shaibani, MD

Neurology · Houston, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
6624 FANNIN ST, Houston, TX 77030
7137950033
In practice since 2005 (20 years)
NPI: 1164423588 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shaibani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shaibani? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shaibani

Dr. Aziz Shaibani is a neurology in Houston, TX, with 20 years in practice. Based on federal Medicare data, Dr. Shaibani performed 8,189 Medicare services across 660 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shaibani received a total of $2,411 from 7 pharmaceutical and/or device companies across 16 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shaibani is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice▲ Top 10% volume in TX$ $2,411 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,189
Medicare services
Top 10% in TX for neurology
660
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~409 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg7,120$39$57
Office visit, established patient (30-39 min)245$89$165
Needle measurement of electrical activity in arm or leg muscles, complete study195$80$185
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour159$17$110
New patient office visit (45-59 min)109$127$275
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less51$53$140
Tissue staining for diagnosis, initial43$74$165
Tissue pathology examination, moderate complexity37$56$140
Nerve conduction, 7-8 studies31$141$375
Office visit, established patient, complex (40-54 min)30$115$240
Needle measurement of electrical activity in trunk or head muscles24$69$175
Nerve conduction, 5-6 studies24$110$285
Testing of autonomic (sympathetic) nervous system function22$99$265
Testing of autonomic (sympathetic and parasympathetic) nervous system function, at least 5 minutes of tilt22$125$310
New patient office visit (30-44 min)22$89$190
Nerve conduction, 3-4 studies16$91$240
Nerve conduction, 1-2 studies15$68$190
Nerve conduction, 9-10 studies13$174$450
Office visit, established patient (20-29 min)11$72$105
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.6% high complexity
86.9% medium
10.5% routine

Industry Payment Transparency

Open Payments through 2023 ↗
$2,411
Total received (2018-2023)
Avg $603/year across 4 years
Top 50% in TX for neurology
7
Companies
16
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,398 (99.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$13 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2023
$18
2022
$157
2019
$151
2018
$2,086

Payments by company (2023)

Consulting
Speaking
Meals & Travel
Research
Orion Corporation
$1,922
CSL Behring
$145
UCB, Inc.
$135
Alexion Pharmaceuticals, Inc.
$120
Octapharma USA, Inc.
$40
Strongbridge US INC.
$36
Mitsubishi Tanabe Pharma America, Inc.
$13
Top 3 companies account for 91.3% of total payments
Associated products mentioned in payments ›
Hizentra · KEVEYIS · PANZYGA · Radicava · SOLIRIS
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $29 per 100 Medicare services performed
Looking for a neurology in Houston?
Compare neurologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
382
Per 100K population
8.0
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2023
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Shaibani is a mixed practice specialist, with above-average Medicare volume (top 10% in TX), and low-engagement industry engagement, with 20 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Shaibani experienced with injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg?
Based on Medicare claims data, Dr. Shaibani performed 7,120 injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shaibani receive payments from pharmaceutical companies?
Yes. Dr. Shaibani received a total of $2,411 from 7 companies across 16 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shaibani's costs compare to other neurologys in Houston?
Dr. Shaibani's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shaibani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →